Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: Marshall Teitelbaum who wrote (420)	11/18/1998 2:36:00 AM
From: kas1	Read Replies (1) \| Respond to of 642

Hi Marshall, I know that both the valium-type drugs and the klonopin-type drugs are benzodiazapines. However, I didn't know that they were ALL habit forming? I thought it was just the older ones that were habit-forming? >Prozac is an effective anti-panic drug, >as much so as any other ssri If you had a pt with depression and panic attacks, why would you script them prozac if you could script paxil? That's what it comes down to, I think. Especially if you've seen SmithKline's marketing on this! Sure, maybe zoloft as a second attempt, prozac as a third, but considering that how many GP's (HMO-supported) are being consulted for psychiatric problems these days, I wonder if there ever is a second or third visit. "Here take this Paxil and don't come back or the HMO will hate me!" BTW, my understanding is that Zyprexa would be battling it out with lithium carbonate (cheap generic!) and depakote for the bipolar market? I am impressed with how well Lilly is marketing its drugs for other purposes. BTW #2, apparently ssri's are being prescribed off-label for premature ejaculation -- wonder how extensive this use is? And whether Lilly is interested in securing FDA approval for such a use? Apologies to readers of the thread if this is off-topic. If anyone requests it, we can take the discussion to private messages. Thanks for your thoughtful reply kas